| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015255225 |
| P356 | DOI | 10.1186/1756-9966-29-90 |
| P932 | PMC publication ID | 2907341 |
| P698 | PubMed publication ID | 20609231 |
| P5875 | ResearchGate publication ID | 45100159 |
| P2093 | author name string | Leos Kren | |
| Ondrej Slaby | |||
| Alexandr Poprach | |||
| Jana Jancovicova | |||
| Jaroslav Michalek | |||
| Marek Svoboda | |||
| Pavel Fabian | |||
| Radek Lakomy | |||
| Rostislav Vyzula | |||
| P2860 | cites work | Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression | Q24647373 |
| A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells | Q24649109 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Micro-RNA profiling in kidney and bladder cancers | Q28247306 | ||
| The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma | Q28268174 | ||
| Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling | Q28297583 | ||
| MicroRNAs in Cancer | Q29615539 | ||
| Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues | Q33403617 | ||
| Non-coding RNAs: a key to future personalized molecular therapy? | Q33762263 | ||
| Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas | Q34097908 | ||
| MicroRNAs: novel biomarkers for human cancer | Q34952989 | ||
| miR-155 gene: a typical multifunctional microRNA. | Q34958384 | ||
| Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma | Q34984233 | ||
| MicroRNA profiling of human kidney cancer subtypes | Q34985875 | ||
| MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy | Q35893422 | ||
| Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer | Q36516410 | ||
| MicroRNA expression and function in cancer | Q36637333 | ||
| Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. | Q37463898 | ||
| Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications | Q37553909 | ||
| Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities | Q37566543 | ||
| MicroRNAs in colorectal cancer: translation of molecular biology into clinical application | Q37632608 | ||
| TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect | Q37663174 | ||
| MicroRNA control of signal transduction | Q37706077 | ||
| Identification of a microRNA panel for clear-cell kidney cancer | Q45714425 | ||
| Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c | Q46053142 | ||
| Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. | Q51562422 | ||
| Microarray analysis of microRNA expression in renal clear cell carcinoma. | Q51566326 | ||
| Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. | Q51806979 | ||
| Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis | Q82783887 | ||
| [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma] | Q84838098 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | renal cell carcinoma | Q1164529 |
| P304 | page(s) | 90 | |
| P577 | publication date | 2010-07-07 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. | |
| P478 | volume | 29 |
| Q42608545 | A Lasso regression model for the construction of microRNA-target regulatory networks |
| Q37453234 | A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese |
| Q64996867 | Analysis of Expression Patterns of MicroRNAs That Are Closely Associated With Renal Carcinogenesis. |
| Q39097822 | Biomarkers of Renal Tumors: the Current State and Clinical Perspectives |
| Q35922727 | Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. |
| Q41883434 | Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma |
| Q47291579 | Decreased MicroRNA miR-181c Expression Associated with Gastric Cancer. |
| Q28071747 | Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol |
| Q37211359 | Differential microRNA expression in renal cell carcinoma |
| Q38699390 | Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN. |
| Q38712436 | Effect of miR-106b on Invasiveness of Pituitary Adenoma via PTEN-PI3K/AKT. |
| Q64105262 | Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma |
| Q88985337 | Epigenetics in renal cell cancer: mechanisms and clinical applications |
| Q35742259 | Expression and clinical significance of the microRNA-200 family in gastric cancer |
| Q36464365 | Expression and functional role of miR-29b in renal cell carcinoma |
| Q36356425 | Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma. |
| Q47163897 | Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics |
| Q58804594 | GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma |
| Q37295196 | Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer |
| Q45020503 | Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients |
| Q36382323 | Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas |
| Q37514211 | Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma |
| Q34287632 | Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava |
| Q36095196 | KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro |
| Q30318519 | Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? |
| Q49335182 | Lysosome-associated membrane protein 2 (LAMP-2) expression induced by miR-194-5p downregulation contributes to sunitinib resistance in human renal cell carcinoma cells |
| Q38261708 | MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma |
| Q39245274 | MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. |
| Q47209993 | MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma |
| Q42317002 | MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients. |
| Q36522330 | MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients |
| Q36326306 | MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone |
| Q54244950 | MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. |
| Q28384675 | MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1 |
| Q47867637 | MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells |
| Q54191921 | MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. |
| Q43440363 | MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma |
| Q38929235 | MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1. |
| Q37828424 | MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs |
| Q26785371 | MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis |
| Q38356005 | MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review). |
| Q36209417 | Novel classes of non-coding RNAs and cancer |
| Q34434075 | Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro |
| Q58578839 | Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma |
| Q40652931 | Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis |
| Q51496684 | Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma. |
| Q26781520 | Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer |
| Q54392904 | Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma. |
| Q51057342 | The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer. |
| Q39257795 | The entire miR-200 seed family is strongly deregulated in clear cell renal cell cancer compared to the proximal tubular epithelial cells of the kidney. |
| Q38016153 | The epigenetics of renal cell tumors: from biology to biomarkers. |
| Q43416814 | The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma |
| Q36960910 | The regulation and function of microRNAs in kidney diseases |
| Q34370023 | Treatment-independent miRNA signature in blood of Wilms tumor patients |
| Q34152578 | Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma |
| Q34667439 | Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma |
| Q38137530 | Urine microRNAs as potential noninvasive biomarkers in urologic cancers. |
| Q39255366 | miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma |
| Q35551941 | miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma |
Search more.